Clinical study evaluating the feasibility and clinical use of continuous subcutaneous levodopa infusion as an adjunct therapy in advanced Parkinson's disease patients who have subthalamic nucleus deep brain stimulation (abstract not provided).

Offers clinically relevant information on combining advanced drug-delivery approaches with DBS for symptomatic management, which can inform translational care strategies but provides limited novel mechanistic or disease-modifying insights for therapeutic discovery.